Unity Software Valuation
Is U * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of U * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: U * (MX$420.45) is trading below our estimate of fair value (MX$463.58)
Significantly Below Fair Value: U * is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for U *?
Other financial metrics that can be useful for relative valuation.
| What is U *'s n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | US$9.48b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 5x |
| Enterprise Value/EBITDA | -55.3x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does U *'s PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 12.2x | ||
CFLT Confluent | 11.5x | 17.2% | US$8.9b |
PCOR Procore Technologies | 10.5x | 16.3% | US$10.0b |
APPF AppFolio | 12.4x | 17.2% | US$8.2b |
LMN Lumine Group | 14.3x | 31.4% | CA$9.7b |
U * Unity Software | 4.4x | 1.6% | Mex$9.5b |
Price-To-Sales vs Peers: U * is good value based on its Price-To-Sales Ratio (4.4x) compared to the peer average (12.1x).
Price to Earnings Ratio vs Industry
How does U *'s PE Ratio compare vs other companies in the Global Software Industry?
Price-To-Sales vs Industry: U * is expensive based on its Price-To-Sales Ratio (4.4x) compared to the Global Software industry average (2.9x).
Price to Sales Ratio vs Fair Ratio
What is U *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 4.4x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate U *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | Mex$420.45 | Mex$519.42 +23.5% | 24.6% | Mex$770.33 | Mex$273.89 | n/a | 21 |
| Apr ’25 | Mex$438.00 | Mex$506.15 +15.6% | 24.6% | Mex$750.65 | Mex$266.90 | n/a | 21 |
| Mar ’25 | Mex$494.00 | Mex$529.68 +7.2% | 24.4% | Mex$765.84 | Mex$272.30 | n/a | 21 |
| Feb ’25 | Mex$546.00 | Mex$594.78 +8.9% | 29.6% | Mex$943.73 | Mex$274.54 | n/a | 22 |
| Jan ’25 | Mex$692.50 | Mex$540.05 -22.0% | 27.0% | Mex$789.72 | Mex$274.69 | n/a | 21 |
| Dec ’24 | Mex$555.00 | Mex$529.40 -4.6% | 29.0% | Mex$796.20 | Mex$276.94 | n/a | 21 |
| Nov ’24 | Mex$438.00 | Mex$771.93 +76.2% | 26.3% | Mex$1,021.18 | Mex$291.76 | n/a | 22 |
| Oct ’24 | Mex$544.25 | Mex$764.72 +40.5% | 25.1% | Mex$976.14 | Mex$278.90 | n/a | 21 |
| Sep ’24 | Mex$640.00 | Mex$749.44 +17.1% | 26.4% | Mex$1,022.07 | Mex$201.06 | n/a | 21 |
| Aug ’24 | Mex$770.07 | Mex$683.02 -11.3% | 31.4% | Mex$1,100.97 | Mex$200.18 | n/a | 20 |
| Jul ’24 | Mex$752.80 | Mex$659.92 -12.3% | 32.2% | Mex$1,127.05 | Mex$204.92 | n/a | 20 |
| Jun ’24 | Mex$515.00 | Mex$640.89 +24.4% | 32.2% | Mex$1,171.55 | Mex$213.01 | n/a | 19 |
| May ’24 | Mex$490.63 | Mex$648.68 +32.2% | 32.9% | Mex$1,208.16 | Mex$216.39 | Mex$420.45 | 19 |
| Apr ’24 | Mex$577.73 | Mex$664.38 +15.0% | 33.3% | Mex$1,227.95 | Mex$219.93 | Mex$438.00 | 18 |
| Mar ’24 | Mex$567.00 | Mex$680.76 +20.1% | 31.2% | Mex$1,233.46 | Mex$294.56 | Mex$494.00 | 18 |
| Feb ’24 | Mex$673.00 | Mex$698.16 +3.7% | 38.6% | Mex$1,335.03 | Mex$300.85 | Mex$546.00 | 20 |
| Jan ’24 | Mex$513.65 | Mex$723.02 +40.8% | 39.9% | Mex$1,393.82 | Mex$314.10 | Mex$692.50 | 20 |
| Dec ’23 | Mex$758.50 | Mex$717.88 -5.4% | 38.8% | Mex$1,371.20 | Mex$309.00 | Mex$555.00 | 21 |
| Nov ’23 | Mex$559.00 | Mex$1,062.52 +90.1% | 35.0% | Mex$2,078.62 | Mex$435.52 | Mex$438.00 | 18 |
| Oct ’23 | Mex$650.00 | Mex$1,143.27 +75.9% | 32.4% | Mex$2,114.54 | Mex$443.05 | Mex$544.25 | 17 |
| Sep ’23 | Mex$825.00 | Mex$1,157.40 +40.3% | 32.6% | Mex$2,117.43 | Mex$443.65 | Mex$640.00 | 16 |
| Aug ’23 | Mex$775.00 | Mex$1,074.34 +38.6% | 39.6% | Mex$2,149.22 | Mex$450.31 | Mex$770.07 | 15 |
| Jul ’23 | Mex$737.45 | Mex$1,310.02 +77.6% | 52.2% | Mex$3,340.54 | Mex$546.63 | Mex$752.80 | 17 |
| Jun ’23 | Mex$768.59 | Mex$1,648.84 +114.5% | 57.3% | Mex$3,870.38 | Mex$578.56 | Mex$515.00 | 17 |
| May ’23 | Mex$1,370.00 | Mex$2,877.40 +110.0% | 24.0% | Mex$3,963.94 | Mex$1,287.26 | Mex$490.63 | 17 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.